View in EDS HTML Full Text PDF Full Text

Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review.

Saved in:
Bibliographic Details
Title: Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review.
Authors: Valerio, Maria Rosaria1 (AUTHOR), Sambataro, Daniela2,3 (AUTHOR), Martorana, Federica3,4,5 (AUTHOR), Greco, Martina1,4 (AUTHOR), Mesi, Chiara1,5 (AUTHOR), Gebbia, Vittorio3,6 (AUTHOR) vittorio.gebbia@unikore.it, Vigneri, Paolo4,5,7 (AUTHOR), Scandurra, Giuseppa3,7 (AUTHOR)
Source: Current Oncology. Apr2026, Vol. 33 Issue 4, p198. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 193441191
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Valerio%2C+Maria+Rosaria%22">Valerio, Maria Rosaria</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sambataro%2C+Daniela%22">Sambataro, Daniela</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martorana%2C+Federica%22">Martorana, Federica</searchLink><relatesTo>3,4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Greco%2C+Martina%22">Greco, Martina</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mesi%2C+Chiara%22">Mesi, Chiara</searchLink><relatesTo>1,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gebbia%2C+Vittorio%22">Gebbia, Vittorio</searchLink><relatesTo>3,6</relatesTo> (AUTHOR)<i> vittorio.gebbia@unikore.it</i><br /><searchLink fieldCode="AR" term="%22Vigneri%2C+Paolo%22">Vigneri, Paolo</searchLink><relatesTo>4,5,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scandurra%2C+Giuseppa%22">Scandurra, Giuseppa</searchLink><relatesTo>3,7</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Current+Oncology%22">Current Oncology</searchLink>. Apr2026, Vol. 33 Issue 4, p198. 20p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=193441191
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/curroncol33040198
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 20
        StartPage: 198
    Titles:
      – TitleFull: Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Valerio, Maria Rosaria
      – PersonEntity:
          Name:
            NameFull: Sambataro, Daniela
      – PersonEntity:
          Name:
            NameFull: Martorana, Federica
      – PersonEntity:
          Name:
            NameFull: Greco, Martina
      – PersonEntity:
          Name:
            NameFull: Mesi, Chiara
      – PersonEntity:
          Name:
            NameFull: Gebbia, Vittorio
      – PersonEntity:
          Name:
            NameFull: Vigneri, Paolo
      – PersonEntity:
          Name:
            NameFull: Scandurra, Giuseppa
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 11980052
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Current Oncology
              Type: main
ResultId 1